Last update 05 Jul 2025

Anti-CD19/CD20 CAR-T cell therapy (Guiguidan Biomedicine)

Overview

Basic Info

Drug Type
CAR-T
Synonyms
CD19/CD20/CARVAC T cells, ICG 132, ICG 134
Target
CD19 x CD20
Action
inhibitors
Mechanism
CD19 inhibitors(B-lymphocyte antigen CD19 inhibitors), CD20 inhibitors(B-lymphocyte antigen CD20 inhibitors), Gene transference(Gene transference)
Therapeutic Areas
NeoplasmsImmune System DiseasesHemic and Lymphatic Diseases
Active Indication-
Inactive Indication
B-Cell Lymphoma
Originator Organization
Icar Bio Therapeutics LtdIcar Bio Therapeutics Ltd
Active Organization-
Inactive Organization
Icar Bio Therapeutics LtdIcar Bio Therapeutics Ltd
License Organization-
Drug Highest PhasePendingEarly Phase 1
First Approval Date-
Regulation-
Login to view timeline

Related

1
Clinical Trials associated with Anti-CD19/CD20 CAR-T cell therapy (Guiguidan Biomedicine)
ChiCTR1900026083
/ RecruitingEarly Phase 1IIT
CD19/CD20/CARVAC-targeted Chimeric antigen receptor gene-modified T cells therapy in Patients with relapsed/refractory B cell malignancies: An open-labled, single-center clinical study of the efficacy and safety
100 Clinical Results associated with Anti-CD19/CD20 CAR-T cell therapy (Guiguidan Biomedicine)
Login to view more data
100 Translational Medicine associated with Anti-CD19/CD20 CAR-T cell therapy (Guiguidan Biomedicine)
Login to view more data
100 Patents (Medical) associated with Anti-CD19/CD20 CAR-T cell therapy (Guiguidan Biomedicine)
Login to view more data
100 Deals associated with Anti-CD19/CD20 CAR-T cell therapy (Guiguidan Biomedicine)
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
B-Cell LymphomaPhase 1
China
Icar Bio Therapeutics LtdIcar Bio Therapeutics Ltd
20 Sep 2019
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free